← Open Payments lookup

ROBIN HINER: Open Payments

NPI 1851099329 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,661 in 95 payments from 12 companies in 2025. Trend: 2023 $140 · 2024 $519 · 2025 $1,661

Food & beverage: $1,661
CompanyPaymentsAmount
Alkermes, Inc.12$308
Neurocrine BioSciences, Inc.14$301
Otsuka America Pharmaceutical, Inc.14$271
E.R. Squibb & Sons, L.L.C.19$213
Teva Pharmaceuticals USA, Inc.15$194
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$181
Axsome Therapeutics, Inc.3$72
Janssen Pharmaceuticals, Inc2$34
Takeda Pharmaceuticals U.S.A., Inc.2$28
Supernus Pharmaceuticals, Inc.1$23

Products named: INGREZZA, ARISTADA, REXULTI, COBENFY, CAPLYTA, UZEDY, Auvelity, TRINTELLIX.

Industry payments across TX — which companies pay providers there.